Page 4 - Best Esophageal cancer doctors: TOP 133 doctors

Assoc. Prof. Nail Paksoy specializes in esophageal cancer treatment at Medipol Bahçelievler Hospital, with extensive research and clinical trial experience.

• ESMO Board Certified in Medical Oncology
• Participated in 8 international clinical trials for various cancers
• Published multiple studies on cancer treatment outcomes
• Fellowship-trained at Istanbul University Oncology Institute

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Dr. Ozden specializes in esophageal cancer treatment with extensive training in medical oncology.

• Graduated from Istanbul University's Cerrahpaşa Faculty of Medicine
• Completed medical oncology subspecialty at Kocaeli University
• Over a decade of experience in internal medicine and oncology
• Practices at VM Medical Park Pendik Hospital

49 years of experience in immunology with a focus on virotherapy – Dr. Jaunalksne brings cutting-edge immunotherapy expertise to esophageal cancer treatment.

• Specializes in virotherapy, a novel approach to cancer treatment
• Head of Clinical Immunology Center at Pauls Stradins Clinical University Hospital
• Graduate of Riga Medical Institute

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Professor Gul Alco specializes in radiation oncology with over 31 years of experience of experience, currently at Istanbul Medipol University.

• Trained at Istanbul University and Kadir Has University
• Associate Professor and later Professor at Demiroglu Bilim University
• Expert in radiation oncology for cancer treatment
• Works at Medipol Acibadem District Hospital

Dr. Muzaffer Al specializes in advanced laparoscopic and oncological cancer surgery, with extensive training at top medical institutions.

• Trained in laparoscopic surgery at Istanbul University Çapa Faculty of Medicine
• Specialized in laparoscopic antireflux surgery and advanced laparoscopic bariatric surgery
• Experience in oncological cancer surgery, including esophageal cancer

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Ezgi Sevic specializes in nutrition for cancer patients, with a focus on esophageal cancer. She graduated as an honor student from Hacettepe University.

• Completed studies on insulin resistance and obesity
• Worked in oncology hospitals and community health centers
• Expert in post-bariatric surgery nutrition
• Advanced English proficiency for international patients

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Specializes in oncological surgery with expertise in esophageal cancer at Büyük Anadolu Hospitals.

• Experienced in pancreatic and bile duct surgeries
• Skilled in gastric and colon cancer procedures
• Performs bariatric metabolic and diabetes surgeries

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

15,000+ surgical procedures performed – Dr. de Lacy is a pioneer in minimally invasive techniques for esophageal cancer at Hospital Quiron Barcelona.

• Performs 1,000+ interventions annually using laparoscopic and robotic methods
• President of the Association of Surgeons-Endoscopists in Europe
• World-renowned pioneer in gastrointestinal surgery techniques
• Lecturer on advanced laparoscopy and surgical techniques

Prof. Keun Chil Park, MD heads the Division of Hematology-Oncology at Samsung Medical Center with a strong focus on esophageal cancer.

• Special interests in lung, head and neck, and esophageal cancers
• Member of multiple prestigious oncology associations including ASCO and ESMO
• Graduated from Seoul National University College of Medicine

Dr. Choi Yong Soo is a thoracic surgeon at Samsung Medical Center, specializing in esophageal cancer treatments.

• Expert in surgical interventions for complex esophageal cancer cases
• Works at one of South Korea's leading medical institutions
• Focuses on providing personalized treatment plans

Professor Haciibrahimoglu specializes in thoracic surgical oncology, including esophageal cancer, with expertise in VATS (Video Assisted Thoracoscopic Surgery).

• Trained at University of Paris-Sud and Vienna Medical School
• Over 76 years of experience of experience in thoracic surgery
• Member of European Society of Thoracic Surgeons
• Published 13 international papers on thoracic surgery